Axon Enterprise, Inc $AXON Stock: Physician Wealth Advisors Inc. Increases Stake

Physician Wealth Advisors Inc. boosted its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 851.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,464 shares of the biotechnology company’s stock after acquiring an additional 3,100 shares during the period. Physician Wealth Advisors Inc.’s holdings in Axon Enterprise were worth $1,464,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of AXON. Keating Financial Advisory Services Inc. acquired a new stake in shares of Axon Enterprise in the second quarter valued at about $31,000. Wealth Enhancement Trust Services Inc. bought a new position in shares of Axon Enterprise in the third quarter worth about $33,000. Washington Trust Advisors Inc. increased its stake in shares of Axon Enterprise by 1,300.0% in the second quarter. Washington Trust Advisors Inc. now owns 70 shares of the biotechnology company’s stock worth $39,000 after purchasing an additional 65 shares during the period. Delos Wealth Advisors LLC acquired a new position in shares of Axon Enterprise during the 2nd quarter worth about $45,000. Finally, Owl Creek Wealth Partners LLC lifted its position in shares of Axon Enterprise by 84.8% during the 2nd quarter. Owl Creek Wealth Partners LLC now owns 85 shares of the biotechnology company’s stock worth $48,000 after purchasing an additional 39 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors.

Insider Transactions at Axon Enterprise

In other news, President Joshua Isner sold 16,775 shares of Axon Enterprise stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the sale, the president owned 296,974 shares of the company’s stock, valued at approximately $170,590,774.82. This trade represents a 5.35% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Jeffrey Kunins sold 9,605 shares of Axon Enterprise stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $626.70, for a total value of $6,019,453.50. Following the sale, the insider directly owned 97,761 shares in the company, valued at $61,266,818.70. The trade was a 8.95% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 47,397 shares of company stock worth $26,722,984 over the last 90 days. Insiders own 4.20% of the company’s stock.

Axon Enterprise Stock Up 2.5%

NASDAQ AXON opened at $392.64 on Wednesday. Axon Enterprise, Inc has a twelve month low of $339.01 and a twelve month high of $764.02. The stock has a market cap of $31.90 billion, a PE ratio of 162.92, a PEG ratio of 7.21 and a beta of 1.44. The firm has a 50-day simple moving average of $492.46 and a 200 day simple moving average of $474.34. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.80 and a current ratio of 2.15.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Wednesday, August 5th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.84 by $0.04. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%. The firm had revenue of $904.39 million for the quarter, compared to analyst estimates of $876.42 million. During the same period in the previous year, the company posted $2.12 earnings per share. The company’s quarterly revenue was up 35.3% compared to the same quarter last year. On average, research analysts forecast that Axon Enterprise, Inc will post 2.12 EPS for the current year.

Key Stories Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon is expected to report third-quarter results soon, with analysts anticipating a substantial year-over-year increase in earnings per share. The earnings preview may be supporting optimism about continued revenue and profit growth. Earnings Preview: What to Expect From Axon Enterprise’s Report
• Positive Sentiment: Bloomington approved an expanded agreement with Axon for policing technology, while the Reno City Council is set to vote on a proposed $22 million deal. Additional municipal contracts could reinforce Axon’s recurring-revenue model and strengthen demand for its connected hardware and cloud software. Bloomington council OKs expanded agreement with Axon for policing technology City of Reno council to vote on $22M Axon tech deal
• Positive Sentiment: Commentary from The Motley Fool describes Axon as a potential buy after a roughly 54% decline, arguing that recent pressure appears largely short-term and that the company retains a dominant position in public safety. Down 54%, This Tech Stock Looks Like a Buy With or Without AI
• Neutral Sentiment: Piper Sandler maintained an “overweight” rating but reduced its AXON price target from $732 to $561. The target cut signals more cautious near-term expectations, although it still implies significant potential upside based on the cited trading level.
• Neutral Sentiment: A comparison with Arista Networks emphasizes Axon’s integrated hardware-and-cloud platform and strong public-safety market position, but it is an opinion piece rather than a new company-specific catalyst. Arista Networks vs. Axon Enterprise
• Neutral Sentiment: Reports concerning an “Axon Graphite” spin-out by Lithium Energy and a reverse stock split by Axonex AI Group are unrelated to Axon Enterprise, Inc. (AXON) and should not affect its shares.

Analyst Ratings Changes

Several brokerages recently weighed in on AXON. Citigroup restated a “market outperform” rating on shares of Axon Enterprise in a research note on Thursday, September 17th. UBS Group lifted their price target on Axon Enterprise from $440.00 to $600.00 and gave the stock a “neutral” rating in a research report on Thursday, August 6th. Needham & Company LLC reiterated a “buy” rating on shares of Axon Enterprise in a report on Wednesday, September 2nd. TD Cowen reiterated a “buy” rating on shares of Axon Enterprise in a report on Tuesday, October 13th. Finally, Royal Bank Of Canada reissued an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, July 21st. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $707.07.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and connected products for public safety organizations. The company’s portfolio includes TASER conducted-energy weapons, body-worn cameras, in-car cameras, and related hardware designed to support law enforcement, corrections, security, and other emergency-response professionals.

Axon also provides cloud-based software for managing digital evidence, records, workflows, real-time operations, investigations, and communications. Its platform is intended to connect hardware, software, and services across the public-safety ecosystem, helping agencies collect, store, analyze, and share operational information.

The company was founded in 1993 as TASER International by Rick Smith and Tom Smith and adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into a broader technology platform.